News

​Rigshospitalet's unit for experimental cancer treatment for children and young people, 'Innovative Medicine for Children with Cancer', has been accredited as an 'Early Phase Centre' in a European network for experimental treatment for children and young people with cancer.

​Professor Anne Tybjærg-Hansen, a consultant at Rigshospitalet, has been awarded the Anitschkow Prize 2018. The focus of her research is on changes in hereditary genes and how they affect the development of cardiovascular diseases

​A small chip the size of your thump can find the fingerprints of a cancer tumour and establish a precise diagnosis in just one week – previously this could take up to six weeks. Since the start of the year, the Department of Pathology at Rigshospitalet has used the chip to help more than 20 children and adults in their treatment for brain cancer.

​In the pursuit of creating a new front line Children's Hospital in Copenhagen, The Novo Nordisk Foundation has awarded three professorships in paediatric surgery within the fields: heart disease, translational reconstruction techniques and fetal therapy and surgery.

​Babies without language cannot communicate what they hear in a hearing test. However, with new technology, physicians can now measure a baby’s brain activity and find out whether the sound is reaching a baby’s ears.

A new research programme will gather activities and cross-disciplinary experts from Aarhus University Hospital and Rigshospitalet to improve treatment for Danish children with brain tumours and reduce late complications and side effects.

A new study shows that the semen quality of young Danish men is still poor despite a marked decline in the proportion of men born by mothers who smoked during pregnancy. 

​As many as 18 patients have been given a new pancreas after Rigshospitalet started to perform transplants again in 2015. So far, the success rate is 100%.

​For the first time in the world, Danish researchers have studied whether stem cells can resurrect saliva production in cancer patients suffering from mouth dryness following chemotherapy and radiotherapy for head and neck cancers. Results from the new study have attracted attention from abroad.

​Danish scientists, led by senior scientist Kristian Almstrup, have developed a new method for assessing sperm quality. The method may be used to predict what kind of fertility treatment childless couples will benefit most from.

​Ten billion small “wells” with room for precisely one strand of DNA were formed using nano-technology in the new DNA chips. Material from patients is placed in the machine. The machine has a very sensitive camera that photographs each "well" and stores information as digital data. Each chip can map the genetic material from 24 individuals. Miriam Yan Juk Guo, Laboratory Technologist, and her colleagues handle a DNA chip with the many small wells. 

​New research results in new recommendations for surgery on children: A single dose of medicine around 20 minutes before the end of surgery can significantly reduce postoperative agitation and pain in children.

​This year, the international KFJ Award has been awarded to Professor Tom Eirik Mollnes from Norway who, together with Rigshospitalet, researches into immunology to discover new ways of treating cardiovascular diseases and severe blood poisoning.

​New research from Rigshospitalet shows that the initial choice of contraception has a significant effect on the number of suicide attempts and suicides among women aged 15 to 33 years.

​New research into the cause of death for diabetes patients under the age of 50 shows that they have a considerable increased risk of cardiovascular disease. 

​Treatment courses for both children and adults have received international accreditation at the highest level. The process has strengthened collaboration and increased focus on donors

​Rigshospitalet's Phase I Unit is heading the world's first trial of new and promising cancer treatment with potential for a major breakthrough within immunotherapy

​​The new hospital wing for children, adolescents and pregnant women at Rigshospitalet, BørneRiget, will have a distinctive characteristic; a building shaped as two hands gathering all children, adolescents and women in labour under one roof while taking care of the whole family.

​New grant of DKK 100 million to promote translation of research results into novel therapies targeting stem cells in blood cancers and diabetes.

​Surprising results from Danish researchers in new diabetes study

​From April 2017 the Australian professor and diabetes expert David McIntyre from the University of Queensland is affiliated with the Center for Pregnant Women with Diabetes at Rigshospitalet. He will investigate options for implementing international guidelines for diagnosing pregnancy-related diabetes in Denmark.

​Horton's disease (cluster headache) is usually considered as a disease found in men. However, research by the Danish Headache Centre shows that women have the same characteristic symptoms and often go misdiagnosed. 

​Children whose mothers have smoked during pregnancy have a weaker retina-brain connection. This is the result of new research by Rigshospitalet, Zealand University Hospital and the University of Copenhagen.

​In a comprehensive study of 1130 Danish boys and 424 Chilean boys, a group of researchers headed by Professor Anders Juul from Rigshospitalet has found two new genes which may help explain why some boys reach puberty later than others.

​Six project teams have submitted their proposals on how the future hospital for children, adolescents and pregnant women at Rigshospitalet should look like.

Canadian Dr. John E. Dick is to receive Rigshospitalet’s International KFJ Award, and part of the honour is for his work in the fight against leukaemia.

​The development of the new children's wing at Rigshospitalet has started long before the construction site is established. As an experiment, the project organisation chose to involve two users in their hiring of a new innovation consultant, to ensure that the users have as much influence as possible.

​A new research programme starting in 2017 will examine how nurses and other health personnel can help people with cancer become more involved in their treatment to improve quality of life.

​Innovation Fund Denmark is investing DKK 25 mill. in new stem-cell treatment for patients suffering from severe heart failure. The treatment has been developed at Rigshospitalet and can reduce waiting times drastically. With this large investment, research and stem cell production are now entering a crucial phase.

Researchers from the Finsen Laboratory and BRIC in collaboration with researchers from Germany and Norway have developed a new computational method for analysis of large data material from thousands of cancer patients. These ‘big data’ can be used to understand how cancer genes are activated which enables targeted therapy especially for patients with aggressive tumours

​Rigshospitalet has examined all the received applications for pre-qualification. Six teams are invited to place a bid. The final winner will be selected during August 2017.

​On 14 October 2016 Rigshospitalet invites you to come join the celebration of Copenhagen Culture Night!

​A simple adjustment to patients' therapeutic regimen may improve the effectiveness of the standard epigenetic treatment for cancers. A pilot clinical trial to test the effectiveness of vitamin C as a booster in regard to myeloid dysplastic syndrome (MDS) and acute myeloid leukemia (AML) treatment.

Mikkel-Ole Skjødt has been granted the recognized "Young Investigator Award" for his pioneering work regarding a new immunoregulatory molecule.

​For patients with symptomatic systolic heart failure not caused by coronary artery disease, an implantable cardioverter-defibrillator (ICD) does not benefit the overall survival, according to a study conducted at the University Hospital in Copenhagen, Denmark.

​Neither gay men nor heterosexual people with HIV transmit the virus to their partner, provided they are on suppressive antiretroviral treatment. This has been demonstrated in the results of the world’s largest study of people with HIV who have had condomless sex with their HIV negative partners.

​A randomized clinical trial comparing transcatheter and surgical aortic valve replacement in younger low risk patients with aortic stenosis.

Danish researchers from EDMaRC at Rigshospitalet, Copenhagen are the first to describe a possible epigenetic link between the environment and pubertal timing. To a large extent, pubertal timing is herita​ble, but the underlying genetic causes are still unexplained. Researchers have now studied how chemical modifications of the human genome (so-called epigenetic modifications​) change when girls and boys enter puberty. The results indicate that such epigenetic chang​​es are involved in defining the onset of puberty. 

​The Capital Region of Denmark, Rigshospitalet and Ole Kirk's Foundation have joined forces in a partnership to build a first-rate hospital building that sets new standards for the treatment of children, adolescents, pregnant women and their families. The working title of the construction project is: Children's Hospital Copenhagen.

​An increasing number of young people experience blood clots in the brain. Young males are particularly at risk. This is the result of a new research study from Rigshospitalet. Although the condition is still rare among young people, the results call for a greater focus on young people with regard to prevention and rehabilitation.  

​The incidence of serious viral infections after transplant surgery at Rigshospitalet has plummeted since infection and transplant specialists began using the MATCH database. Odense University Hospital and Aarhus University Hospital are now joining the collaborative work.

​New Intensive Care Department project will use big data to build models to better predict treatment paths and treatment impacts for intensive-care patients.

​​​The Master of Headache Disorders is a new continuing medical education for health care professionals with experience in headache medicine. ​​

​A new study from Rigshospitalet finds that many ultraviolet (UV)-filtering chemicals commonly used in sunscreens interfere with the function of human sperm cells. "These results are of concern and might explain in part why unexplained infertility is so prevalent," said the study's senior investigator, Prof. Niels Skakkebaek, MD, DMSc.